GSD I has an estimated incidence of 1 in 100,000 births.[1]Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov;16(11):e1.
https://www.gimjournal.org/article/S1098-3600(21)02651-4/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/25356975?tool=bestpractice.com
Approximately 80% of people with GSD have GSD 1a and 20% have GSD 1b.[1]Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov;16(11):e1.
https://www.gimjournal.org/article/S1098-3600(21)02651-4/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/25356975?tool=bestpractice.com
GSD I affects sexes equally and is transmitted as an autosomal recessive trait.
For both subtypes, common pathogenic genetic variants have been recognized. Common G6PC1 variants include p.R83C (in people of European descent, Turkish people, and Ashkenazi Jewish people), p.Q347* (in European people), c.648G>T (in Chinese, Japanese, and Korean people), and c.380insTA (in Hispanic people).[4]Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type 1 and G6Pase-beta deficiency: etiology and therapy. Nat Rev Endocrinol. 2010 Dec;6(12):676-88.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178929
http://www.ncbi.nlm.nih.gov/pubmed/20975743?tool=bestpractice.com
[5]Ekstein J, Rubin BY, Anderson SL, et al. Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population. Am J Med Genet A. 2004 Aug 30;129A(2):162-4.
http://www.ncbi.nlm.nih.gov/pubmed/15316959?tool=bestpractice.com
[6]Seydewitz HH, Matern D. Molecular genetic analysis of 40 patients with glycogen storage disease type Ia: 100% mutation detection rate and 5 novel mutations. Hum Mutat. 2000 Jan;15(1):115-6.
https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1098-1004(200001)15:1%3C115::AID-HUMU23%3E3.0.CO;2-W
http://www.ncbi.nlm.nih.gov/pubmed/10612834?tool=bestpractice.com
[7]Kim YM, Choi JH, Lee BH, et al. Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia. Orphanet J Rare Dis. 2020 Feb 11;15(1):45.
https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-1321-0
http://www.ncbi.nlm.nih.gov/pubmed/32046761?tool=bestpractice.com
[8]Lei KJ, Chen YT, Chen H, et al. Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet. 1995 Oct;57(4):766-71.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801521
http://www.ncbi.nlm.nih.gov/pubmed/7573034?tool=bestpractice.com
[9]Chou JY, Matern D, Mansfield BC, et al. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med. 2002 Mar;2(2):121-43.
http://www.ncbi.nlm.nih.gov/pubmed/11949931?tool=bestpractice.com
The overall carrier rate is about 1 in 150; however, GSD Ia is more common among those with Ashkenazi Jewish heritage in whom approximately 1 in 70 are carriers.[5]Ekstein J, Rubin BY, Anderson SL, et al. Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population. Am J Med Genet A. 2004 Aug 30;129A(2):162-4.
http://www.ncbi.nlm.nih.gov/pubmed/15316959?tool=bestpractice.com
Common SLC37A4 (encoding the glucose-6-phosphate transporter, G6PT) variants include p.W118R, p.G339C and c.1042_1043delCT.[10]Beyzaei Z, Geramizadeh B. Molecular diagnosis of glycogen storage disease type I: a review. EXCLI J. 2019 Jan 30:18:30-46.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449677
http://www.ncbi.nlm.nih.gov/pubmed/30956637?tool=bestpractice.com